• Far broader and more inclusive of Lyme Borreliae species than standard serologies.
• Detects antibodies to Lyme Borreliae species from North American, European and Australian strains.
• Better than two-tier ELISA/WB and two-tier ELISA.
• Provides a simple, cost-effective, yes/no result with no complicated interpretation necessary.
Test
Lyme Screen Immunoassay IgM
$195.00
The Lyme Screen Immunoassay IgM is a qualitative test designed to detect IgM antibodies to Lyme Borreliae group-specific antigens in human serum. The sensitivity of the Lyme Screen Immunoassay IgM is 90%, and the specificity is 97%.
Principle
The test detects IgM and IgG antibodies to the Lyme Borreliae group, and should be used in conjunction with patient clinical symptoms and history.
Tube / Specimen Requirements
1 SST/ minimum volume 0.5mL serum
CPT Code(s)
86618
Sample Report
View
Positive: Lyme Borreliae antigens detected
Negative: Lyme Borreliae antigens not detected
- For specific protein or band information, an ImmunoBlot IgM or IgG test should be ordered to provide more information and possible speciation of the Borrelia.
- A negative Lyme Screen Immunoassay IgM does not exclude the possibility of infection with B. burgdorferi.
- IGeneX interpretation is based on internal validation studies.
- The results of this test must be interpreted in relation to patient’s clinical history, epidemiological data, stage of disease, clinical symptoms or other laboratory results.
Related Tests
GET STARTED TODAY!
The first step in getting tested with IGeneX is to order a collection kit. Choose between a Blood, Urine, or Miscellaneous kit.
WHY IGENEX FOR TICK-BORNE DISEASE TESTING?
- CLIA certified in all 50 states
- Long track record of success since 1991
- Offers testing that is nearly twice as accurate as CDC recommended tests
- Tests for all major tick-borne illnesses, including Lyme disease, TBRF, Babesia, Bartonella, and Rickettsia
- Utilizes comprehensive testing methods such as PCR, ImmunoBlots, IgXSpot and FISH
- Has become a nationwide leader in COVID-19 testing due to a relentless focus on customer satisfaction
